Literature DB >> 27884972

Increased serum hepcidin contributes to the anemia of chronic kidney disease in a murine model.

Mark R Hanudel1, Maxime Rappaport2, Victoria Gabayan3, Grace Jung3, Isidro B Salusky2, Elizabeta Nemeth3, Tomas Ganz3,4, Joshua Zaritsky5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27884972      PMCID： PMC5394962          DOI： 10.3324/haematol.2016.150433

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   11.047


× No keyword cloud information.
  15 in total

Review 1.  Current status of the measurement of blood hepcidin levels in chronic kidney disease.

Authors:  Iain C Macdougall; Jolanta Malyszko; Robert C Hider; Sukhvinder S Bansal
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-19       Impact factor: 8.237

2.  Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age.

Authors:  Bryan J McCranor; Jacqueline M Langdon; Olivier D Prince; Laurette K Femnou; Alan E Berger; Chris Cheadle; Curt I Civin; Airie Kim; Seth Rivera; Tomas Ganz; Sophie Vaulont; Qian-Li Xue; Jeremy D Walston; Cindy N Roy
Journal:  Haematologica       Date:  2013-08-30       Impact factor: 9.941

3.  Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation.

Authors:  Cindy N Roy; Howard H Mak; Imo Akpan; Grigoriy Losyev; David Zurakowski; Nancy C Andrews
Journal:  Blood       Date:  2007-01-11       Impact factor: 22.113

4.  Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.

Authors:  Jason S Troutt; Anthony M Butterfield; Robert J Konrad
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

5.  Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease.

Authors:  Oleh Akchurin; Angara Sureshbabu; Steve B Doty; Yuan-Shan Zhu; Edwin Patino; Susanna Cunningham-Rundles; Mary E Choi; Adele Boskey; Stefano Rivella
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-20

6.  Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study.

Authors:  Claudine T Jurkovitz; Jerome L Abramson; L Viola Vaccarino; William S Weintraub; William M McClellan
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

7.  Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.

Authors:  Joshua Zaritsky; Brian Young; He-Jing Wang; Mark Westerman; Gordana Olbina; Elizabeta Nemeth; Tomas Ganz; Seth Rivera; Allen R Nissenson; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

8.  Immunoassay for human serum hepcidin.

Authors:  Tomas Ganz; Gordana Olbina; Domenico Girelli; Elizabeta Nemeth; Mark Westerman
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

9.  Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

Authors:  Lynda A Szczech; Huiman X Barnhart; Jula K Inrig; Donal N Reddan; Shelly Sapp; Robert M Califf; Uptal D Patel; Ajay K Singh
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

10.  A novel model of adenine-induced tubulointerstitial nephropathy in mice.

Authors:  Ting Jia; Hannes Olauson; Karolina Lindberg; Risul Amin; Karin Edvardsson; Bengt Lindholm; Göran Andersson; Annika Wernerson; Yves Sabbagh; Susan Schiavi; Tobias E Larsson
Journal:  BMC Nephrol       Date:  2013-05-30       Impact factor: 2.388
View more
  6 in total

1.  Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin.

Authors:  Mark R Hanudel; Brian Czaya; Shirley Wong; Maxime Rappaport; Shweta Namjoshi; Kristine Chua; Grace Jung; Victoria Gabayan; Bo Qiao; Elizabeta Nemeth; Tomas Ganz
Journal:  Kidney Int       Date:  2021-11-25       Impact factor: 10.612

2.  Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice.

Authors:  Richard Coffey; Grace Jung; Joseph D Olivera; Gabriel Karin; Renata C Pereira; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood       Date:  2022-01-20       Impact factor: 22.113

Review 3.  Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.

Authors:  Daniel N Srole; Tomas Ganz
Journal:  J Cell Physiol       Date:  2020-12-28       Impact factor: 6.513

4.  First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis.

Authors:  Lutz Renders; Klemens Budde; Christian Rosenberger; Rachel van Swelm; Dorine Swinkels; Frank Dellanna; Werner Feuerer; Ming Wen; Christiane Erley; Birgit Bader; Claudia Sommerer; Matthias Schaier; Karoline Meurer; Louis Matis
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

5.  Experimental modulation of Interleukin 1 shows its key role in chronic kidney disease progression and anemia.

Authors:  Yael Segev; Daniel Landau; Inbar Bandach
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

6.  Saccharated ferric oxide attenuates haematopoietic response induced by epoetin beta pegol in patients undergoing haemodialysis.

Authors:  Takahide Iwasaki; Akira Fujimori; Takeshi Nakanishi; Shioko Okada; Nobuto Hanawa; Yukiko Hasuike; Takahiro Kuragano
Journal:  BMC Nephrol       Date:  2021-04-08       Impact factor: 2.388
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.